These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8222720)
1. Antimicrobial activity and in vitro corneal epithelial toxicity of antimicrobial agents for gram-positive corneal pathogens. Cutarelli PE; Lazarus HM; Jacobs MR; Lass JH Curr Eye Res; 1993 Jul; 12(7):603-8. PubMed ID: 8222720 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of LY146032 (daptomycin), a new peptolide. Ehlert F; Neu HC Eur J Clin Microbiol; 1987 Feb; 6(1):84-90. PubMed ID: 3032611 [TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci]. Bezian MC; Ribou G; Masquelier B Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667 [TBL] [Abstract][Full Text] [Related]
4. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Low DE; McGeer A; Poon R Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286 [TBL] [Abstract][Full Text] [Related]
5. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution]. Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353 [TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333 [TBL] [Abstract][Full Text] [Related]
7. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution]. Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of the new glycopeptide decaplanin. Neu HC; Chin NX; Niu WW Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci. Kenny MT; Dulworth JK; Brackman MA Diagn Microbiol Infect Dis; 1991; 14(1):29-31. PubMed ID: 1826479 [TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile. Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341 [TBL] [Abstract][Full Text] [Related]
11. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. Pohlod DJ; Saravolatz LD; Somerville MM J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646 [TBL] [Abstract][Full Text] [Related]
12. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862 [TBL] [Abstract][Full Text] [Related]
14. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci. Sachdeva M; Hackbarth C; Stella FB; Chambers HF Antimicrob Agents Chemother; 1987 Oct; 31(10):1549-52. PubMed ID: 3481245 [TBL] [Abstract][Full Text] [Related]
15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757 [TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]